NCT06740890View on ClinicalTrials.gov

Exercise and Olanzapine-samidorphan

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 26, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Schizophenia DisorderSchizoaffective DisorderBipolar Disorder I or IIBipolar Disorder NOS
Interventions
DRUG

Olanzapine-samidorphan + exercise

8 weeks of open label Olanzapine-samidorphan + 4 weeks of aerobic exercise

Trial Locations (1)

10032

RECRUITING

New York State Psychiatric Institute, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER